F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Shanghai Simnova Biotechnology Co.,Ltd.
Shanghai Simnova Biotechnology Co.,Ltd.
Qilu Pharmaceutical Co., Ltd.
Chongqing Precision Biotech Co., Ltd
Melbourne Health
Athenex, Inc.
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital of Soochow University
Ascentage Pharma Group Inc.
Lanzhou Institute of Biological Products Co., Ltd
Jiangsu HengRui Medicine Co., Ltd.
Beijing Boren Hospital
Zhejiang University
Shanghai Miracogen Inc.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
UWELL Biopharma
Oncotartis, Inc.
M.D. Anderson Cancer Center
Timmune Biotech Inc.
Peking University
Ruijin Hospital
Chinese PLA General Hospital
Beijing Immunochina Medical Science & Technology Co., Ltd.
Henan Cancer Hospital
Shanghai AbelZeta Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
Cambridge Antibody Technology
Novacea
Corixa Corporation